Find Reports

Select Report Type

Reimbursement Review

Displaying 226 - 250 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
cenegermin	Oxervate	cenegermin	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Neurotrophic keratitis	Reimburse with clinical criteria and/or conditions	Complete	Oct 29, 2021	Jun 23, 2022	SR0704-000
Human Epidermal Growth Factor ...			Final Report	Esophageal or Gastroesophageal Junction Cancer		Complete		Jun 21, 2022	PH0010-000
tafamidis	Vyndaqel	tafamidis	Recommendation and Reasons Request for Advice Report Stakeholder feedback on Draft Recommendation	Transthyretin-mediated amyloidosis	Reimburse with clinical criteria and/or conditions	Complete	Dec 14, 2021	Jun 17, 2022	SF0722-000
elexacaftor/tezacaftor/ivacaft...	Trikafta	elexacaftor/tezacaftor/ivacaftor and ivacaftor	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Cystic fibrosis, F508del CFTR mutation, 6 years and older	Reimburse with clinical criteria and/or conditions	Complete	Nov 5, 2021	Jun 17, 2022	SR0710-000
amifampridine phosphate	Firdapse	amifampridine phosphate	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Lambert-Eaton Myasthenic Syndrome, adults	Reimburse with clinical criteria and/or conditions	Complete	Nov 15, 2021	Jun 16, 2022	SR0664-000
immune globulin human and reco...	HyQvia	immune globulin human and recombinant human hyaluronidase	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submission Stakeholder feedback on Draft Recommendation	Humoral immunodeficiency	Reimburse with clinical criteria and/or conditions	Complete	Jun 24, 2021	Jun 15, 2022	ST0695-000
upadacitinib	Rinvoq	upadacitinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	atopic dermatitis	Reimburse with clinical criteria and/or conditions	Complete	Apr 13, 2021	Jun 8, 2022	SR0685-000
cemiplimab	Libtayo	cemiplimab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Non-small cell lung cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 13, 2021	Jun 2, 2022	PC0262-000
Multiple myeloma			Multiple myeloma - Final Report	Multiple myeloma		Complete		May 25, 2022	PH0011-000
Anaplastic Lymphoma Kinase Pos...			Final Report	ALK-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer		Complete		May 24, 2022	PH0009-000
ospemifene	Osphena	ospemifene	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Dyspareunia, vaginal dryness	Reimburse with clinical criteria and/or conditions	Complete	Oct 26, 2021	May 13, 2022	SR0709-000
selpercatinib	Retevmo	selpercatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	RET fusion-positive non-small cell lung cancer	Reimburse with clinical criteria and/or conditions	Complete	Aug 17, 2021	Apr 28, 2022	PC0261-000
ripretinib	Qinlock	ripretinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Gastrointestinal stromal tumours	Reimburse with clinical criteria and/or conditions	Complete	Oct 15, 2021	Apr 28, 2022	PC0265-000
prasterone	Intrarosa	prasterone	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Postmenopausal vulvovaginal atrophy	Reimburse with clinical criteria and/or conditions	Complete	Oct 1, 2021	Apr 14, 2022	SR0707-000
Alpha1-proteinase inhibitor (H...	Zemaira	Alpha1-proteinase inhibitor (Human)	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Severe Alpha1-proteinase inhibitor deficiency	Reimburse with clinical criteria and/or conditions	Complete	Oct 1, 2021	Apr 13, 2022	ST0702-000
HER2-Positive Metastatic Breas...			Final Report	HER2-Positive Metastatic Breast Cancer		Complete		Apr 12, 2022	PH0006-000
fostamatinib	Tavalisse	fostamatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation	Chronic immune thrombocytopenia	Do not reimburse	Complete	Jul 22, 2021	Apr 5, 2022	SR0701-000
bimekizumab	Bimzelx	bimekizumab	Recommendation and Reasons: Updated Recommendation and Reasons: Original Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Psoriasis, moderate to severe plaque	Reimburse with clinical criteria and/or conditions	Complete	Aug 17, 2021	Mar 30, 2022	SR0698-000
Metastatic Urothelial Carcinom...			Final Report	Metastatic Urothelial Carcinoma		Complete		Mar 28, 2022	PH0008-000
pemigatinib	Pemazyre	pemigatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submission Stakeholder feedback on Draft Recommendation	Cholangiocarcinoma	Do not reimburse	Complete	Jun 23, 2021	Mar 23, 2022	PC0252-000
lorlatinib	Lorbrena	lorlatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation	ALK-positive locally advanced or metastatic non-small cell lung	Reimburse with clinical criteria and/or conditions	Complete	Jun 18, 2021	Mar 17, 2022	PC0249-000
somatrogon	Ngenla	somatrogon	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Growth hormone deficiency	Reimburse with clinical criteria and/or conditions	Complete	Jun 3, 2021	Mar 8, 2022	SR0683-000
colchicine	Myinfla	colchicine	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Atherothrombotic events in coronary artery disease	Do not reimburse	Complete	May 28, 2021	Mar 8, 2022	SR0691-000
tralokinumab	Adtralza	tralokinumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Clinician Input Stakeholder feedback on Draft Recommendation	atopic dermatitis	Do not reimburse	Complete	Apr 27, 2021	Mar 7, 2022	SR0689-000
nivolumab	Opdivo	nivolumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Gastric, gastroesophageal junction, or esophageal adenocarcinoma	Reimburse with clinical criteria and/or conditions	Complete	Aug 18, 2021	Mar 4, 2022	PC0259-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 226 - 250 of 600

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Transanal Total Mesorectal Excision for Adult Patients with Rectal Cancer	Transanal Total Mesorectal Excision for Adult Patients with Rectal Cancer	Nov 7, 2022	Rapid Review	Completed	RC1459-000
Liposuction for Lymphedema	Liposuction for Lymphedema	Nov 2, 2022	Rapid Review	Completed	RC1458-000
Oral Feeding for Preterm Infants on Respiratory Support	Oral Feeding for Preterm Infants on Respiratory Support	Oct 31, 2022	Rapid Review	Completed	RC1461-000
Rural Healthcare Planning Initiatives and Frameworks	Rural Healthcare Planning Initiatives and Frameworks	Oct 28, 2022	Health Technology Assessment	Completed	HC0044-000
Intravenous Iron Isomaltoside for Patients with Iron Deficiency Undergoing Elective Surgery	Intravenous Iron Isomaltoside for Patients with Iron Deficiency Undergoing Elec…	Oct 28, 2022	Rapid Review	Completed	RC1456-000
Pediatric Glioma Learning Project	Pediatric Low-Grade Glioma Pre-Meeting Material Pediatric Low-Grade Glioma Multi-stakeholder Dialogue Methods and Practice Repo…Pediatric Low-Grade Glioma Multi-stakeholder Dialogue Lessons Learned Report Scientific Poster	Oct 27, 2022	Technology Review	Active	HM0001-000
Evusheld for the Treatment of Mild to Moderate COVID-19	Evusheld for the Treatment of Mild to Moderate COVID-19	Oct 26, 2022	Technology Review	Completed	HC0041-000
Azacitidine for Acute myeloid leukemia	Azacitidine for Acute myeloid leukemia	Oct 24, 2022	Technology Review	Completed	HC0036-000
Real-Time Continuous Glucose Monitoring: A Review of Guidelines	Real-Time Continuous Glucose Monitoring: A Review of Guidelines	Oct 24, 2022	Summary with Critical Appraisal	Completed	RC1449-000
Treatment Strategies for Sexual Dysfunction Associated With Psychotropic Medications	Treatment Strategies for Sexual Dysfunction Associated With Psychotropic Medica…	Oct 13, 2022	Rapid Review	Completed	RC1455-000
Delayed Tuberculin Skin Testing	Delayed Tuberculin Skin Testing	Oct 7, 2022	Rapid Review	Completed	RC1452-000
Internet-Delivered Cognitive Behavioural Therapy in the Treatment of Chronic Non-Cancer Pain	Internet-Delivered Cognitive Behavioural Therapy in the Treatment of Chronic No…Project Protocol	Oct 3, 2022	Optimal Use	Completed	HT0037-000 - OP0550-000
Cannabis for Opioid Use Disorder	Cannabis for Opioid Use Disorder	Oct 3, 2022	Rapid Review	Completed	RC1454-000
Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes	Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes	Sep 28, 2022	Rapid Review	Completed	RC1443-000
Mepivacaine Versus Bupivacaine for Patients Undergoing Total Joint Arthroplasty	Mepivacaine Versus Bupivacaine for Patients Undergoing Total Joint Arthroplasty	Sep 22, 2022	Rapid Review	Completed	RC1453-000
Therapeutic Support for Pressure Injuries	Therapeutic Support for Pressure Injuries	Sep 15, 2022	Rapid Review	Completed	RC1450-000
Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An Update	Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An…	Sep 15, 2022	Rapid Review	Completed	RC1451-000
Antiviral Prophylaxis With Tenofovir for Patients With History of Hepatitis B Receiving Oncology Drug Treatment	Antiviral Prophylaxis With Tenofovir for Patients With History of Hepatitis B R…	Sep 9, 2022	Rapid Review	Completed	RC1448-000
RWE Learning Project Non-Oncology: Ocaliva		Sep 8, 2022	Technology Review	In Progress	HC0046-000
Considerations for the use of COVID-19 Rapid Tests	Considerations for the use of COVID-19 Rapid Tests	Sep 2, 2022	Environmental Scan	Completed	ES0364-000
Utilization of Glucagon-Like Peptide-1 Receptor Agonists	Utilization of Glucagon-Like Peptide-1 Receptor Agonists	Sep 1, 2022	Technology Review	Completed	HC0042-000
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes	Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes	Aug 22, 2022	Rapid Review	Completed	RC1442-000
Health Technology Assessment Recommendations and Managed Entry Agreements Related to Optimizing the Treatment for Pediatric Spinal Muscular Atrophy		Aug 17, 2022	Environmental Scan	In Progress	ES0368-000
Virtual Care Use in Primary Care or Specialty Care Settings	Virtual Care Use in Primary Care or Specialty Care Settings In-Brief Guidelines for use of virtual care in primary care or specialty care s…	Aug 17, 2022	Rapid Review	Completed	RC1444-000
Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza	Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza	Aug 15, 2022	Rapid Review	Completed	RC1446-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 226 - 250 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
ivosidenib	Recommendation and Reason Patient and Clinician Group Input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Jan 21, 2025	Reimbursement Review		Complete	PC0349-000
Virtual Mental Health Counselling	Virtual Mental Health Counselling	Jan 20, 2025	Health Technology Review	Rapid Review	Completed	RC1569-000
cariprazine	Recommendation and Reason Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Jan 17, 2025	Reimbursement Review		Complete	SR0827-000
secukinumab	Recommendation and Reasons Patient and Clinician Group input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Jan 17, 2025	Reimbursement Review		Complete	SR0781-000
Endometrial cancer	Scoping Document Scoping Document for PH0066-000	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Active	PH0076-000
Multiple myeloma	Scoping Document Proposed Project Scope for PH0060-000	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0074-000
Mesothelioma	Proposed Scope	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Active	PH0077-000
Prostate cancer	Proposed Scope	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0073-000
Hodgkin lymphoma	Proposed Scope	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0079-000
Diffuse large B cell lymphoma (DLBCL)	Proposed Scope	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0078-000
Renal cell carcinoma	Scoping Document	Jan 16, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0075-000
cabotegravir	Recommendation and Reason Patient and Clinician Group Input Clinical and Pharmacoeconomic Combined Report Stakeholder feedback on Draft Recommendation	Jan 14, 2025	Reimbursement Review		Complete	SR0825-000
Methadone for Surgical Patients	Methadone for Surgical Patients	Jan 9, 2025	Health Technology Review	Rapid Review	Completed	RC1565-000
remdesivir	Recommendation and Reason Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Jan 8, 2025	Reimbursement Review		Complete	SR0833-000
fidaxomicin	Proposed Scope	Jan 7, 2025	Reimbursement Review		Active	SX0754-000
nivolumab	Proposed Scope	Jan 7, 2025	Reimbursement Review		Active	PX0376-000
delgocitinib	Patient and Clinician Group input	Jan 7, 2025	Reimbursement Review		Received	SR0875-000
inclisiran	Recommendation and Reasons Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Dec 20, 2024	Reimbursement Review		Complete	SR0791-001
inclisiran	Recommendation and Reasons Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Dec 20, 2024	Reimbursement Review		Complete	SR0791-000
Brentuximab vedotin	Recommendation and Reasons Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Dec 17, 2024	Reimbursement Review		Complete	PC0371-000
Antiviral Drugs for the Treatment of Suspected or Confirmed Influenza A or Influenza B		Dec 16, 2024	Health Technology Review	Systematic Review	In Progress	RE0052-000
Icatibant Implementation Advice Panel	Implementation Advice for Icatibant	Dec 16, 2024	Health Technology Review	Technology Review	Completed	HC0097-000 - SX0849-000
donanemab	Patient and Clinician Group input	Dec 16, 2024	Reimbursement Review		Suspended	SR0857-000
lecanemab	Patient and Clinician Group input	Dec 16, 2024	Reimbursement Review		Suspended	SR0822-000
atogepant	Recommendation and Reason Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group input	Dec 16, 2024	Reimbursement Review		Complete	SR0817-000